Fig. 1From: NS34A resistance-associated substitutions in chronic hepatitis C in Upper Egypt and regression of liver fibrosis after direct-acting antiviral therapyRelation between fibrosis stage before and 72 weeks after SMV/SOF therapyBack to article page